$WEYL news: Dec. 05, 2019 (GLOBE NEWSWIRE) -- Weyland Tech,

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
214
$WEYL news: Dec. 05, 2019 (GLOBE NEWSWIRE) -- Weyland Tech, Inc. a leading global Platform-as-a-Service (PaaS) provider of m-Commerce and fintech solutions, is supporting an upcoming launch of a new mobile app on Android and iOS for Push Interactive’s AstrologyNova horoscope community. This announcement follows Weyland Tech announcing last week its plans to acquire Push.

“Weyland’s earlier work with Push to support the North American introduction of our CreateApp platform led to this strategic acquisition and now co-developed mobile app,” said Eddie Foong, Weyland’s chief product officer and founder of CreateApp. “The AstrologyNova app has been one of our initial joint projects and a technology testbed for enhancing our mutual platforms as we prepare CreateApp for a major rollout to the U.S. SMB market. This includes new tools and APIs now in place for tighter, more robust platform integration and an expanded product pipeline.”

While the AstrologyNova app demonstrates the valuable synergies of the respective platforms and sets the stage for revenue stream expansion, it also highlights some of the significant brand value Push brings to the table. Push not only provides end-to-end eCommerce services for SMB and major brands, but also has valuable brands of its own like AstrologyNova.

AstrologyNova taps the growing online ‘mystical services’ market currently valued at more than $2 billion. Since the launch of AstrologyNova.com in 2016, signups have doubled year over year to now reaching more than 1 million subscribers. Hundreds of thousands of subscribers are active daily on the AstrologyNova online channel, which includes Facebook and other social media outlets. More than a million customized astrological readings are emailed daily to subscribers based on their submitted information, including career goals, marital status and personal aspirations.

AstrologyNova’s basic subscription is free, with upgrade options of $4.99 and $9.99 per month to receive more personalized astrological readings and predictions, as well as other types of mystical readings based on numerology and Tarot. AstrologyNova also generates revenue from targeted advertising via Google, Outbrain and PowerInbox and other ad partners, and users can be re-engaged and remarketed for other products and services.

The new CreateApp-powered mobile app will offer a new level of accessibility and interaction for AstrologyNova subscribers, while providing Push deeper insights into user activity and personal preferences that can lead to greater conversions and monetization.

The Weyland CreateApp platform enables SMBs to deploy native mobile applications without technical knowledge or background. Offered in 14 languages with more than 70 integrated modules, it empowers businesses to increase sales, reach more customers, manage logistics, and promote their products and services via mobile in an easy, affordable and highly efficient way.

“We attribute AstrologyNova’s rapid user growth to our data driven lead capture campaigns, optimized sales funnel, and proprietary content collection and delivery platform,” commented Push’s chief technology officer, Tom Furukawa. “We see the new native mobile app driving further acceleration and broader market reach, particularly with younger demographics who are more mobile centric. In addition to driving U.S. subscriber growth, Weyland’s strong presence in Southeast Asia and CreateApp’s multi-language support opens up a huge new international market for AstrologyNova in a turn-key fashion.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 5

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 1

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Thor Equities Sells Amazon Distribution Center for $157M

Updated Category News Views 191

Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...

Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand

Updated Category News Views 169

Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...

Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth

Updated Category News Views 341

Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....

Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights

Updated Category News Views 175

Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....

Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation

Updated Category News Views 181

Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...

Continue Reading